MIB-1 immunoreactivity correlates with metastatic dissemination in primary thick cutaneous melanoma
- 30 September 1996
- journal article
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 35 (3), 416-418
- https://doi.org/10.1016/s0190-9622(96)90607-6
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- MIB-1 Proliferative Activity Is a Significant Prognostic Factor in Primary Thick Cutaneous MelanomasJournal of Investigative Dermatology, 1995
- Comparison of proliferative activity as assessed by proliferating cell nuclear antigen (PCNA) and Ki‐67 monoclonal antibodies in melanocytic skin lesionsJournal of Cutaneous Pathology, 1993
- Effects of systemic interferon-α (IFN-α) on the antigenic phenotype of melanoma metastases. EORTC melanoma group cooperative study No. 18852Melanoma Research, 1993
- Monoclonal antibodies against recombinant parts of the Ki‐67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave‐processed formalin‐fixed paraffin sectionsThe Journal of Pathology, 1992
- The Ki-67 antigen in primary human melanomas ?its relationship to mitotic rate and tumor thickness and its stabilityArchives of Dermatological Research, 1989
- Cell proliferation kinetics in human solid tumors: relation to probability of metastatic dissemination and long-term survivalRadiotherapy and Oncology, 1989
- Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).Journal of Histochemistry & Cytochemistry, 1984
- Thickness, Cross-Sectional Areas and Depth of Invasion in the Prognosis of Cutaneous MelanomaAnnals of Surgery, 1970